Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Global Med Device Leader Anthrex Reveals Big Expansion Plans

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:BioPharma

Less than one month after announcing plans for construction of a South Carolina manufacturing facility, Arthrex announces its plans for the expansion of its global headquarters in Florida. Source: BioSpace

Continue ReadingGlobal Med Device Leader Anthrex Reveals Big Expansion Plans

Booming Abeona Plans to Hire Dozens of New Employees in Expansion

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:BioPharma

Abeona Therapeutics has plans to expand its facilities and hire an additional 25 to 40 employees. Source: BioSpace

Continue ReadingBooming Abeona Plans to Hire Dozens of New Employees in Expansion

IM Therapeutics Spins Out of University of Colorado to Focus on Type 1 Diabetes

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:BioPharma

ImmunoMolecular Therapeputics officially launched yesterday. Source: BioSpace

Continue ReadingIM Therapeutics Spins Out of University of Colorado to Focus on Type 1 Diabetes

Sangamo Inks Deal for New HQ in Bay Area Biotech Hub

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:BioPharma

Sangamo is moving its corporate headquarters to a new site at Oyster Point in Brisbane, CA. Source: BioSpace

Continue ReadingSangamo Inks Deal for New HQ in Bay Area Biotech Hub

How Sweet It Is: Dynavax Finally Wins FDA OK for Hep B Vaccine Heplisav

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:BioPharma

The FDA approved Dynavax's Heplisav-B, it's first new hepatitis B vaccine in the U.S. in more than 25 years. Source: BioSpace

Continue ReadingHow Sweet It Is: Dynavax Finally Wins FDA OK for Hep B Vaccine Heplisav

As the IDO Battle Gets Ugly, Bristol-Myers Shows Off Early Data for Combo Trial

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:BioPharma

BMS is pushing forward with its internal IDO1 program and showing off early-stage data from its Phase I/IIa combination trial of Opdivo plus BMS-986205, an IDO1 inhibitor. Source: BioSpace

Continue ReadingAs the IDO Battle Gets Ugly, Bristol-Myers Shows Off Early Data for Combo Trial

Valeant Providing Reporters With an Earnings Metric the SEC Ordered it to Stop Using

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:BioPharma

Valeant is not the only company to recently push reporters to defy the SEC’s orders. Source: BioSpace

Continue ReadingValeant Providing Reporters With an Earnings Metric the SEC Ordered it to Stop Using

Former Eli Lilly Exec Expected to be Named Trump's HHS Secretary

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:BioPharma

President Donald Trump could be close to naming former Eli Lilly exec Alex Azar as new Secretary of HHS, according to reports. Source: BioSpace

Continue ReadingFormer Eli Lilly Exec Expected to be Named Trump's HHS Secretary

How GlaxoSmithKline Lost Nearly $10B in October

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:BioPharma

Could GlaxoSmithKline's industry-leading dividend be at risk? Source: BioSpace

Continue ReadingHow GlaxoSmithKline Lost Nearly $10B in October

Sunovion Announces FDA Acceptance for Review of New Drug Application for Dasotraline for the Trea…

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:BioPharma

The NDA submission is supported by multiple placebo-controlled safety and efficacy studies, as well as two long-term studies that assessed the safety of dasotraline in people with ADHD for up…

Continue ReadingSunovion Announces FDA Acceptance for Review of New Drug Application for Dasotraline for the Trea…
  • Go to the previous page
  • 1
  • …
  • 262
  • 263
  • 264
  • 265
  • 266
  • 267
  • 268
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.